• Source: Atoltivimab

Atoltivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).




References






External links


"Atoltivimab". Drug Information Portal. U.S. National Library of Medicine.
"Statement on a nonproprietary name adopted by the USAN Council USAN (FG-87) Atoltivimab" (PDF).

Kata Kunci Pencarian:

• Atoltivimab/maftivimab/odesivimab
• Atoltivimab
• Ebola
• WHO Model List of Essential Medicines
• Research in management of Ebola
• Regeneron Pharmaceuticals
• Remdesivir
• List of therapeutic monoclonal antibodies
• Odesivimab
• ZMapp